TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: To better understand the molecular landscape of tRCC and identify potential therapeutic targets, we performed a genetic analysis of tRCC patients diagnosed based on TFE3 overexpression using immunohistochemical (IHC) staining16.